Bank of America’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.14K | Sell |
|
|||||
|
2025
Q1 | $11.9K | Sell |
|
|||||
|
2024
Q4 | $26.3K | Sell |
|
|||||
|
2024
Q3 | $51.6K | Sell |
|
|||||
|
2024
Q2 | $131K | Buy |
|
|||||
|
2024
Q1 | $153K | Sell |
|
|||||
|
2023
Q4 | $160K | Sell |
|
|||||
|
2023
Q3 | $163K | Buy |
|
|||||
|
2023
Q2 | $51.7K | Sell |
|
|||||
|
2023
Q1 | $161K | Sell |
|
|||||
|
2022
Q4 | $953K | Sell |
|
|||||
|
2022
Q3 | $1.11M | Buy |
|
|||||
|
2022
Q2 | $697K | Sell |
|
|||||
|
2022
Q1 | $933K | Buy |
|
|||||
|
2021
Q4 | $977K | Buy |
|
|||||
|
2021
Q3 | $222K | Buy |
|
|||||
|
2021
Q2 | $145K | Sell |
|
|||||
|
2021
Q1 | $711K | Buy |
|
|||||
|
2020
Q4 | $35K | Buy |
|
|||||
|
2020
Q3 | $0 | Buy |
|